Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 4 of the 13 calendar months from Oct 2025 to Oct 2026: Feb 2026, May 2026, Jun 2026 and Sep 2026.
- Largest single sale: $3.2M (16,602 shares) of Jazz Pharmaceuticals plc on Feb 26, 2026. Filing
- Last sale before this period: Feb 27, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Jazz Pharmaceuticals plc (JAZZ) | EVP & Chief Legal Officer | Aug 12, 2019 | Sep 14, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 10, 2026, Jazz Pharmaceuticals plc: sold 1,200 shares for $289K, under a disclosed plan. 1 filing: 1
- Jun 30, 2026, Jazz Pharmaceuticals plc: 2,678 shares withheld by the company for taxes. 1 filing: 1
- Jun 10, 2026, Jazz Pharmaceuticals plc: sold 1,200 shares for $278K, under a disclosed plan. 1 filing: 1
- May 28, 2026, Jazz Pharmaceuticals plc: sold 1,192 shares for $282K, under a disclosed plan. 1 filing: 1
- Mar 5, 2026, Jazz Pharmaceuticals plc: 5,000 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.